Biotech · Private company · Durham, NC, US
Nabgen, Inc.
Track this companyFree. Adds Nabgen, Inc. to your Dealase workspace and tells you when its record changes.
Clinical trials0None registered
Pipeline programs0None found yet
Disclosed deals0None found yet
Cash runwayNot availablePrivate: no SEC financials
NIH awards3
- Development of a universal approach to block inhibitors for protein replacement therapyFiscal year 2026 · $312.5KNIH RePORTER 1R41TR006064-01 · fetched Nov 12, 2026
- Novel strategy to block AAV neutralizing antibody activityFiscal year 2026 · $1MNIH RePORTER 5R42TR004338-03 · fetched Nov 12, 2026
- Novel strategy to block AAV neutralizing antibody activityFiscal year 2025 · $993.9KNIH RePORTER 2R42TR004338-02 · fetched Nov 12, 2026